Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169061278> ?p ?o ?g. }
- W2169061278 endingPage "5" @default.
- W2169061278 startingPage "281" @default.
- W2169061278 abstract "In their review of the Rye histopathological classification of Hodgkin's disease, Bennett and coworkers have proposed that the nodular sclerosis (NS) type should be divided into two diagnostic categories on the basis of their clinical behaviour. In order to evaluate whether the proliferative activity of HD cells might correlate with histology in NS subtypes, we reviewed and re-evaluated cryostat and paraffin-embedded sections from 80 cases sent to our centre from 1986 to 1991.In the present study, we investigated the growth cell fraction of 53 cases of Hodgkin's disease with nodular sclerosis by using Ki67 and MIB1 monoclonal antibodies to determine whether proliferative activity is associated with different pathological subtypes and prognostic categories. Eight cases with an interfollicular pattern and 19 with mixed cellularity were also investigated. The results in each group were compared to the others.The values of Ki67 and MIB1 were highly correlated (r = 0.88). In Hodgkin's disease with nodular sclerosis, two groups with significantly different growth fractions were morphologically identified: one with lymphocyte predominance and mixed cellularity subtypes, another composed of cases with variously extensive lymphocyte depletion. The figures were compared with those of interfollicular subtype, which fell into the first group, and of mixed cellularity type, in which the proliferative cell activity was significantly higher than in the second nodular sclerosis group. In all cases, Reed-Sternberg and Hodgkin cells accounted for the majority of the cell growth fraction, although a variable percentage of T-lymphocytes were also Ki67- or MIB1-positive. Taking the median value (15%) of MIB1 positive cells as a cut-off, a significant correlation (p = 0.05) was observed between MIB1 positivity and bulky disease, and a good trend (but not a significant relationship) between MIB1 and overall survival, disease-free survival, staging and the clinical response to therapy.Assessment of the growth cell fraction in Hodgkin's disease with different nodular sclerosis patterns provides biological support for the morphological reclassification of their degree of malignancy into two main groups with different impacts on the clinical parameters and a possible relation with the outcome of treatment." @default.
- W2169061278 created "2016-06-24" @default.
- W2169061278 creator A5008033534 @default.
- W2169061278 creator A5013703327 @default.
- W2169061278 creator A5017573437 @default.
- W2169061278 creator A5029799965 @default.
- W2169061278 creator A5051385314 @default.
- W2169061278 creator A5056844291 @default.
- W2169061278 creator A5061172384 @default.
- W2169061278 creator A5078306266 @default.
- W2169061278 date "1997-05-01" @default.
- W2169061278 modified "2023-10-18" @default.
- W2169061278 title "Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies." @default.
- W2169061278 cites W106812279 @default.
- W2169061278 cites W1490020081 @default.
- W2169061278 cites W162120726 @default.
- W2169061278 cites W1623441181 @default.
- W2169061278 cites W1971305947 @default.
- W2169061278 cites W1976254791 @default.
- W2169061278 cites W1991226842 @default.
- W2169061278 cites W2006236067 @default.
- W2169061278 cites W2026060974 @default.
- W2169061278 cites W2030382356 @default.
- W2169061278 cites W2037817195 @default.
- W2169061278 cites W2052557821 @default.
- W2169061278 cites W2072418481 @default.
- W2169061278 cites W2096428903 @default.
- W2169061278 cites W2107610136 @default.
- W2169061278 cites W2112510014 @default.
- W2169061278 cites W2124314287 @default.
- W2169061278 cites W2139689572 @default.
- W2169061278 cites W2168769461 @default.
- W2169061278 cites W22643866 @default.
- W2169061278 cites W2270980578 @default.
- W2169061278 cites W2284588582 @default.
- W2169061278 cites W2326930439 @default.
- W2169061278 cites W2328457637 @default.
- W2169061278 cites W2330793793 @default.
- W2169061278 cites W234781323 @default.
- W2169061278 cites W56548831 @default.
- W2169061278 cites W66824183 @default.
- W2169061278 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9234572" @default.
- W2169061278 hasPublicationYear "1997" @default.
- W2169061278 type Work @default.
- W2169061278 sameAs 2169061278 @default.
- W2169061278 citedByCount "9" @default.
- W2169061278 countsByYear W21690612782012 @default.
- W2169061278 countsByYear W21690612782018 @default.
- W2169061278 crossrefType "journal-article" @default.
- W2169061278 hasAuthorship W2169061278A5008033534 @default.
- W2169061278 hasAuthorship W2169061278A5013703327 @default.
- W2169061278 hasAuthorship W2169061278A5017573437 @default.
- W2169061278 hasAuthorship W2169061278A5029799965 @default.
- W2169061278 hasAuthorship W2169061278A5051385314 @default.
- W2169061278 hasAuthorship W2169061278A5056844291 @default.
- W2169061278 hasAuthorship W2169061278A5061172384 @default.
- W2169061278 hasAuthorship W2169061278A5078306266 @default.
- W2169061278 hasConcept C142724271 @default.
- W2169061278 hasConcept C159654299 @default.
- W2169061278 hasConcept C163864487 @default.
- W2169061278 hasConcept C203014093 @default.
- W2169061278 hasConcept C204232928 @default.
- W2169061278 hasConcept C207886595 @default.
- W2169061278 hasConcept C2776085573 @default.
- W2169061278 hasConcept C2777761686 @default.
- W2169061278 hasConcept C2779338263 @default.
- W2169061278 hasConcept C2780430958 @default.
- W2169061278 hasConcept C2780640218 @default.
- W2169061278 hasConcept C2910938049 @default.
- W2169061278 hasConcept C2992779791 @default.
- W2169061278 hasConcept C542903549 @default.
- W2169061278 hasConcept C57742111 @default.
- W2169061278 hasConcept C71924100 @default.
- W2169061278 hasConcept C86803240 @default.
- W2169061278 hasConceptScore W2169061278C142724271 @default.
- W2169061278 hasConceptScore W2169061278C159654299 @default.
- W2169061278 hasConceptScore W2169061278C163864487 @default.
- W2169061278 hasConceptScore W2169061278C203014093 @default.
- W2169061278 hasConceptScore W2169061278C204232928 @default.
- W2169061278 hasConceptScore W2169061278C207886595 @default.
- W2169061278 hasConceptScore W2169061278C2776085573 @default.
- W2169061278 hasConceptScore W2169061278C2777761686 @default.
- W2169061278 hasConceptScore W2169061278C2779338263 @default.
- W2169061278 hasConceptScore W2169061278C2780430958 @default.
- W2169061278 hasConceptScore W2169061278C2780640218 @default.
- W2169061278 hasConceptScore W2169061278C2910938049 @default.
- W2169061278 hasConceptScore W2169061278C2992779791 @default.
- W2169061278 hasConceptScore W2169061278C542903549 @default.
- W2169061278 hasConceptScore W2169061278C57742111 @default.
- W2169061278 hasConceptScore W2169061278C71924100 @default.
- W2169061278 hasConceptScore W2169061278C86803240 @default.
- W2169061278 hasIssue "3" @default.
- W2169061278 hasLocation W21690612781 @default.
- W2169061278 hasOpenAccess W2169061278 @default.
- W2169061278 hasPrimaryLocation W21690612781 @default.
- W2169061278 hasRelatedWork W169857821 @default.
- W2169061278 hasRelatedWork W1977533465 @default.
- W2169061278 hasRelatedWork W2012072976 @default.